New Delhi, Jan. 29 -- Jenburkt Pharmaceuticals Q3 Results 2025:Jenburkt Pharmaceuticals declared their Q3 results on 28 Jan, 2025. The topline increased by 3.45% & the profit increased by 20.56% YoY. Profit at Rs.6.51 crore and revenue at Rs.36.89 crore.

However, as compared to the previous quarter, the revenue declined by 10.5% and the profit decreased by 32.19%. Despite the quarterly decline, the company showed a significant year-over-year increase.

The Selling, general & administrative expenses declined by 12.78% q-o-q & decreased by 5.54% Y-o-Y, indicating improved cost management strategies.

The operating income was down by 25.49% q-o-q but increased by 22.37% Y-o-Y, reflecting the company's recovery trajectory compared to the sam...